Anti-NMDA receptor encephalitis and MOG-associated demyelination - a case report with long-term follow-up and a systematic review

BMC Neurol. 2022 Nov 16;22(1):434. doi: 10.1186/s12883-022-02974-x.

Abstract

Background: Overlap syndromes of anti-NMDA receptor encephalitis and MOG-mediated demyelination have been reported. In this case we provide a long-term longitudinal follow-up of clinical and imaging characteristics as well as of antibody dynamics.

Case presentation: We report a 32-year-old male patient who presented with psychosis, decreased consciousness and movement disorders and was tested positive for anti-NMDA receptor antibodies. Forty-four months after symptom onset and diagnosis of autoimmune encephalitis, he suffered from relapse. At this time, the patient developed anti-MOG and anti-Caspr2 antibodies. Treatment with plasmapheresis, steroids and rituximab eventually led to substantial clinical and radiological improvement. Anti-Caspr2 antibodies persisted, anti-NMDA receptor antibodies decreased, while anti-MOG antibodies turned negative again.

Conclusion: We provide long-term longitudinal follow-up of a patient with anti-NMDA receptor encephalitis who developed triple antibody positivity at the time of relapse. Antibody dynamics were associated with clinical disease course.

Keywords: Anti-N-Methyl-D-Aspartate; Case report; Demyelination; Encephalitis; Myelin Oligodendrocyte Glycoprotein; NMDA.

Publication types

  • Systematic Review
  • Case Reports

MeSH terms

  • Adult
  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis* / complications
  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis* / diagnosis
  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis* / therapy
  • Autoantibodies
  • Demyelinating Diseases*
  • Follow-Up Studies
  • Humans
  • Male
  • Myelin-Oligodendrocyte Glycoprotein
  • Neoplasm Recurrence, Local
  • Receptors, N-Methyl-D-Aspartate

Substances

  • Myelin-Oligodendrocyte Glycoprotein
  • anti-CASPR2 autoantibody
  • Autoantibodies
  • Receptors, N-Methyl-D-Aspartate